메뉴 건너뛰기




Volumn 24, Issue 10, 2013, Pages 861-870

Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; DNA VACCINE; INTERLEUKIN 2;

EID: 84885404725     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.102     Document Type: Article
Times cited : (26)

References (58)
  • 1
    • 84865580488 scopus 로고    scopus 로고
    • Low-dose IL-2 for in vivo expansion of CD4+ and CD8+ regulatory T cells in nonhuman primates
    • Aoyama, A., Klarin, D., Yamada, Y., et al. (2012). Low-dose IL-2 for in vivo expansion of CD4+ and CD8+ regulatory T cells in nonhuman primates. Am. J. Transplant. 12, 2532-2537.
    • (2012) Am. J. Transplant. , vol.12 , pp. 2532-2537
    • Aoyama, A.1    Klarin, D.2    Yamada, Y.3
  • 2
    • 84867437406 scopus 로고    scopus 로고
    • Im-munotherapy against HPV16/18 generates potent TH1 and cy-totoxic cellular immune responses
    • Bagarazzi, M.L., Yan, J., Morrow, M.P., et al. (2012). Im-munotherapy against HPV16/18 generates potent TH1 and cy-totoxic cellular immune responses. Sci. Transl. Med. 4, 155ra138.
    • (2012) Sci. Transl. Med. , vol.4
    • Bagarazzi, M.L.1    Yan, J.2    Morrow, M.P.3
  • 3
    • 0038128194 scopus 로고    scopus 로고
    • Cutting edge: Rapid in vivo killing by memory CD8 T cells
    • Barber, D.L., Wherry, E.J., and Ahmed, R. (2003). Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171, 27-31.
    • (2003) J. Immunol. , vol.171 , pp. 27-31
    • Barber, D.L.1    Wherry, E.J.2    Ahmed, R.3
  • 4
    • 50849126768 scopus 로고    scopus 로고
    • Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia
    • Bosch, F.X., Burchell, A.N., Schiffman, M., et al. (2008). Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 Suppl 10, K1-K16.
    • (2008) Vaccine , vol.26 , Issue.SUPPL. 10
    • Bosch, F.X.1    Burchell, A.N.2    Schiffman, M.3
  • 5
    • 0034652784 scopus 로고    scopus 로고
    • Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
    • Chen, C.H., Wang, T.L., Hung, C.F., et al. (2000). Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 60, 1035-1042.
    • (2000) Cancer Res. , vol.60 , pp. 1035-1042
    • Chen, C.H.1    Wang, T.L.2    Hung, C.F.3
  • 6
    • 0034788572 scopus 로고    scopus 로고
    • Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
    • Cheng, W.F., Hung, C.F., Chai, C.Y., et al. (2001). Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Clin. Invest. 108, 669-678.
    • (2001) J. Clin. Invest. , vol.108 , pp. 669-678
    • Cheng, W.F.1    Hung, C.F.2    Chai, C.Y.3
  • 7
    • 0036204348 scopus 로고    scopus 로고
    • Cancer im-munotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
    • Cheng, W.F., Hung, C.F., Hsu, K.F., et al. (2002). Cancer im-munotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion. Hum. Gene Ther. 13, 553-568.
    • (2002) Hum. Gene Ther. , vol.13 , pp. 553-568
    • Cheng, W.F.1    Hung, C.F.2    Hsu, K.F.3
  • 8
    • 0031060327 scopus 로고    scopus 로고
    • Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
    • Chow, Y.H., Huang, W.L., Chi, W.K., et al. (1997). Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71, 169-178.
    • (1997) J. Virol. , vol.71 , pp. 169-178
    • Chow, Y.H.1    Huang, W.L.2    Chi, W.K.3
  • 9
    • 0031953116 scopus 로고    scopus 로고
    • Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by co-delivery of various cytokine genes
    • Chow, Y.H., Chiang, B.L., Lee, Y.L., et al. (1998). Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by co-delivery of various cytokine genes. J. Immunol. 160, 1320-1329.
    • (1998) J. Immunol. , vol.160 , pp. 1320-1329
    • Chow, Y.H.1    Chiang, B.L.2    Lee, Y.L.3
  • 10
    • 0034527326 scopus 로고    scopus 로고
    • Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7
    • Chu, N.R., Wu, H.B., Wu, T.C., et al. (2000). Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7. Cell Stress Chaperones 5, 401-405.
    • (2000) Cell Stress Chaperones , vol.5 , pp. 401-405
    • Chu, N.R.1    Wu, H.B.2    Wu, T.C.3
  • 11
    • 0029820526 scopus 로고    scopus 로고
    • DNA-based immunization by in vivo transfection of dendritic cells
    • Condon, C., Watkins, S.C., Celluzzi, C.M., et al. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122-1128.
    • (1996) Nat. Med. , vol.2 , pp. 1122-1128
    • Condon, C.1    Watkins, S.C.2    Celluzzi, C.M.3
  • 12
    • 0037019901 scopus 로고    scopus 로고
    • Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine
    • de Jong, A., O'Neill, T., Khan, A.Y., et al. (2002). Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine. Vaccine 20, 3456-3464.
    • (2002) Vaccine , vol.20 , pp. 3456-3464
    • De Jong, A.1    O'Neill, T.2    Khan, A.Y.3
  • 13
    • 79958039517 scopus 로고    scopus 로고
    • Enhanced anti-tumor effects of a gene gun delivered DNA vaccine encoding the human papillomavirus type-16 (HPV-16) oncoproteins genetically fused to the herpes virus glycoprotein D (gD)
    • Diniz, M.O., and Ferreira, L.C. (2011). Enhanced anti-tumor effects of a gene gun delivered DNA vaccine encoding the human papillomavirus type-16 (HPV-16) oncoproteins genetically fused to the herpes virus glycoprotein D (gD). Braz. J. Biomed. Res. 44, 421-427.
    • (2011) Braz. J. Biomed. Res. , vol.44 , pp. 421-427
    • Diniz, M.O.1    Ferreira, L.C.2
  • 14
    • 77957863130 scopus 로고    scopus 로고
    • Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glyco-protein D
    • Diniz, M.O., Lasaro, M.O., Ertl, H.C., and Ferreira, L.C. (2010). Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glyco-protein D. Clin. Vaccine Immunol. 17, 1576-1583.
    • (2010) Clin. Vaccine Immunol. , vol.17 , pp. 1576-1583
    • Diniz, M.O.1    Lasaro, M.O.2    Ertl, H.C.3    Ferreira, L.C.4
  • 15
    • 0029201560 scopus 로고
    • Cytokines as vaccine adjuvants: Current status and potential applications
    • Dong, P., Brunn, C., and Ho, R.J. (1995). Cytokines as vaccine adjuvants: current status and potential applications. Pharm. Biotechnol. 6, 625-643.
    • (1995) Pharm. Biotechnol. , vol.6 , pp. 625-643
    • Dong, P.1    Brunn, C.2    Ho, R.J.3
  • 16
    • 34548128005 scopus 로고    scopus 로고
    • Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
    • Einstein, M.H., Kadish, A.S., Burk, R.D., et al. (2007). Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III Gynecol. Oncol. 106, 453-460.
    • (2007) Gynecol. Oncol. , vol.106 , pp. 453-460
    • Einstein, M.H.1    Kadish, A.S.2    Burk, R.D.3
  • 17
    • 0019429671 scopus 로고
    • Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2
    • Farrar, W.L., Johnson, H.M., and Farrar, J.J. (1981). Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J. Immunol. 126, 1120-1125.
    • (1981) J. Immunol. , vol.126 , pp. 1120-1125
    • Farrar, W.L.1    Johnson, H.M.2    Farrar, J.J.3
  • 18
    • 0027320440 scopus 로고
    • Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillo-mavirus type 16-transformed cells
    • Feltkamp, M.C., Smits, H.L., Vierboom, M.P., et al. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillo-mavirus type 16-transformed cells. Eur. J. Immunol. 23, 2242-2249.
    • (1993) Eur. J. Immunol. , vol.23 , pp. 2242-2249
    • Feltkamp, M.C.1    Smits, H.L.2    Vierboom, M.P.3
  • 19
    • 1442305202 scopus 로고    scopus 로고
    • ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: A randomized controlled trial
    • Garcia, F., Petry, K.U., Muderspach, L., et al. (2004). ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstet. Gynecol. 103, 317-326.
    • (2004) Obstet. Gynecol. , vol.103 , pp. 317-326
    • Garcia, F.1    Petry, K.U.2    Muderspach, L.3
  • 20
    • 0031066827 scopus 로고    scopus 로고
    • Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
    • Geissler, M., Gesien, A., Tokushige, K., and Wands, J.R. (1997). Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158, 1231-1237.
    • (1997) J. Immunol. , vol.158 , pp. 1231-1237
    • Geissler, M.1    Gesien, A.2    Tokushige, K.3    Wands, J.R.4
  • 21
    • 0036114412 scopus 로고    scopus 로고
    • Activity of HspE7, a novel immunotherapy, in patients with anogenital warts
    • Goldstone, S.E., Palefsky, J.M., Winnett, M.T., and Neefe, J.R. (2002). Activity of HspE7, a novel immunotherapy, in patients with anogenital warts. Dis. Colon Rectum 45, 502-507.
    • (2002) Dis. Colon Rectum , vol.45 , pp. 502-507
    • Goldstone, S.E.1    Palefsky, J.M.2    Winnett, M.T.3    Neefe, J.R.4
  • 22
    • 0029177445 scopus 로고
    • Cytokines as immunological adjuvants
    • Heath, A.W. (1995). Cytokines as immunological adjuvants. Pharm. Biotechnol. 6, 645-658.
    • (1995) Pharm. Biotechnol. , vol.6 , pp. 645-658
    • Heath, A.W.1
  • 23
    • 41149160918 scopus 로고    scopus 로고
    • Antigen-specific immunotherapy of cervical and ovarian cancer
    • Hung, C.F., Wu, T.C., Monie, A., and Roden, R. (2008). Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol. Rev. 222, 43-69.
    • (2008) Immunol. Rev. , vol.222 , pp. 43-69
    • Hung, C.F.1    Wu, T.C.2    Monie, A.3    Roden, R.4
  • 24
    • 0036786797 scopus 로고    scopus 로고
    • Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic ker-atitis
    • Inoue, T., Inoue, Y., Hayashi, K., et al. (2002). Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic ker-atitis. Cornea 21, S79-S85.
    • (2002) Cornea , vol.21
    • Inoue, T.1    Inoue, Y.2    Hayashi, K.3
  • 25
    • 0031569963 scopus 로고    scopus 로고
    • Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
    • Iwasaki, A., Stiernholm, B.J., Chan, A.K., et al. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591-4601.
    • (1997) J. Immunol. , vol.158 , pp. 4591-4601
    • Iwasaki, A.1    Stiernholm, B.J.2    Chan, A.K.3
  • 26
    • 84859575285 scopus 로고    scopus 로고
    • Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced antitumor effects
    • Kang, T.H., Mao, C.P., He, L., et al. (2012). Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced antitumor effects. PLoS One 7, e35141.
    • (2012) PLoS One , vol.7
    • Kang, T.H.1    Mao, C.P.2    He, L.3
  • 27
    • 58549113969 scopus 로고    scopus 로고
    • Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity
    • Karanam, B., Gambhira, R., Peng, S., et al. (2009). Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. Vaccine 27, 1040-1049.
    • (2009) Vaccine , vol.27 , pp. 1040-1049
    • Karanam, B.1    Gambhira, R.2    Peng, S.3
  • 28
    • 40549129230 scopus 로고    scopus 로고
    • Phase i immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity
    • Kenter, G.G., Welters, M.J., Valentijn, A.R., et al. (2008). Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity. Clin. Cancer Res. 14, 169-177.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 169-177
    • Kenter, G.G.1    Welters, M.J.2    Valentijn, A.R.3
  • 29
    • 0034802089 scopus 로고    scopus 로고
    • Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8 T-cell responses that home to the tumor site
    • Lamikanra, A., Pan, Z.K., Isaacs, S.N., et al. (2001). Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8 T-cell responses that home to the tumor site. J. Virol. 75, 9654-9664.
    • (2001) J. Virol. , vol.75 , pp. 9654-9664
    • Lamikanra, A.1    Pan, Z.K.2    Isaacs, S.N.3
  • 30
    • 63349088416 scopus 로고    scopus 로고
    • Potentiating vaccine im-munogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system
    • Lasaro, M.O., and Ertl, H.C. (2009). Potentiating vaccine im-munogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system. Hum. Vaccin. 5, 6-14.
    • (2009) Hum. Vaccin. , vol.5 , pp. 6-14
    • Lasaro, M.O.1    Ertl, H.C.2
  • 31
    • 28944442195 scopus 로고    scopus 로고
    • Antitumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from human herpes virus-1
    • Lasaro, M.O., Diniz, M.O., Reyes-Sandoval, A., et al. (2005). Antitumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from human herpes virus-1. Microb. Infection 7, 1541-1550.
    • (2005) Microb. Infection , vol.7 , pp. 1541-1550
    • Lasaro, M.O.1    Diniz, M.O.2    Reyes-Sandoval, A.3
  • 32
    • 38949214015 scopus 로고    scopus 로고
    • Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses
    • Lasaro, M.O., Tatsis, N., Hensley, S.E., et al. (2008). Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nat. Med. 14, 205-212.
    • (2008) Nat. Med. , vol.14 , pp. 205-212
    • Lasaro, M.O.1    Tatsis, N.2    Hensley, S.E.3
  • 33
    • 62549120308 scopus 로고    scopus 로고
    • HPV vaccination: The beginning of the end of cervical cancer? A review
    • Lepique, A.P., Rabachini, T., and Villa, L.L. (2009). HPV vaccination: the beginning of the end of cervical cancer? A review. Mem. Inst. Oswaldo Cruz. 104, 1-10.
    • (2009) Mem. Inst. Oswaldo Cruz. , vol.104 , pp. 1-10
    • Lepique, A.P.1    Rabachini, T.2    Villa, L.L.3
  • 34
    • 44749088862 scopus 로고    scopus 로고
    • Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting
    • Li, W., Li, S., Hu, Y., et al. (2008). Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting. Vaccine 26, 3282-3290.
    • (2008) Vaccine , vol.26 , pp. 3282-3290
    • Li, W.1    Li, S.2    Hu, Y.3
  • 35
    • 0030068375 scopus 로고    scopus 로고
    • Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
    • Lin, K.Y., Guarnieri, F.G., Staveley-O'Carroll, K.F., et al. (1996). Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
    • (1996) Cancer Res. , vol.56 , pp. 21-26
    • Lin, K.Y.1    Guarnieri, F.G.2    Staveley-O'Carroll, K.F.3
  • 36
    • 36549019001 scopus 로고    scopus 로고
    • DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity
    • Lin, C.T., Tsai, Y.C., He, L., et al. (2007). DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity. Immunol. Lett. 114, 86-93.
    • (2007) Immunol. Lett. , vol.114 , pp. 86-93
    • Lin, C.T.1    Tsai, Y.C.2    He, L.3
  • 37
    • 0033994625 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
    • Liu, D.W., Tsao, Y.P., Kung, J.T., et al. (2000). Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J. Virol. 74, 2888-2894.
    • (2000) J. Virol. , vol.74 , pp. 2888-2894
    • Liu, D.W.1    Tsao, Y.P.2    Kung, J.T.3
  • 38
    • 77952940985 scopus 로고    scopus 로고
    • HPV and therapeutic vaccines: Where are we in 2010?
    • Ma, B., Xu, Y., Hung, C.F., and Wu, T.C. (2010). HPV and therapeutic vaccines: where are we in 2010? Curr. Cancer Ther. Rev. 6, 81-103.
    • (2010) Curr. Cancer Ther. Rev. , vol.6 , pp. 81-103
    • Ma, B.1    Xu, Y.2    Hung, C.F.3    Wu, T.C.4
  • 41
    • 82955240694 scopus 로고    scopus 로고
    • Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T-cell responses and confers protective antitumor immunity
    • Porchia, B.F., Diniz, M.O., Cariri, F.A., et al. (2011). Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T-cell responses and confers protective antitumor immunity. Mol. Pharm. 8, 2320-2330.
    • (2011) Mol. Pharm. , vol.8 , pp. 2320-2330
    • Porchia, B.F.1    Diniz, M.O.2    Cariri, F.A.3
  • 42
    • 0024426529 scopus 로고
    • Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients
    • Rosenberg, S.A., Lotze, M.T., Yang, J.C., et al. (1989). Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg. 210, 474-485.
    • (1989) Ann. Surg. , vol.210 , pp. 474-485
    • Rosenberg, S.A.1    Lotze, M.T.2    Yang, J.C.3
  • 43
    • 54049119238 scopus 로고    scopus 로고
    • Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D
    • Sciortino, M.T., Medici, M.A., Marino-Merlo, F., et al. (2008). Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D. Cell Mi-crobiol. 10, 2297-2311.
    • (2008) Cell Mi-crobiol. , vol.10 , pp. 2297-2311
    • Sciortino, M.T.1    Medici, M.A.2    Marino-Merlo, F.3
  • 44
    • 0038405322 scopus 로고    scopus 로고
    • Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA
    • Sheets, E.E., Urban, R.G., Crum, C.P., et al. (2003). Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am. J. Obstet. Gynecol. 188, 916-926.
    • (2003) Am. J. Obstet. Gynecol. , vol.188 , pp. 916-926
    • Sheets, E.E.1    Urban, R.G.2    Crum, C.P.3
  • 45
    • 0034103589 scopus 로고    scopus 로고
    • Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer
    • Song, K., Chang, Y., and Prud'homme, G.J. (2000). Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Gene Ther. 7, 481-492.
    • (2000) Gene Ther. , vol.7 , pp. 481-492
    • Song, K.1    Chang, Y.2    Prud'Homme, G.J.3
  • 46
    • 80054850189 scopus 로고    scopus 로고
    • The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
    • Steinberg, M.W., Cheung, T.C., and Ware, C.F. (2011). The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol. Rev. 244, 169-187.
    • (2011) Immunol. Rev. , vol.244 , pp. 169-187
    • Steinberg, M.W.1    Cheung, T.C.2    Ware, C.F.3
  • 48
    • 34447272278 scopus 로고    scopus 로고
    • The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection
    • Toubaji, A., Hill, S., Terabe, M., et al. (2007). The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. Vaccine 25, 5882-5891.
    • (2007) Vaccine , vol.25 , pp. 5882-5891
    • Toubaji, A.1    Hill, S.2    Terabe, M.3
  • 49
    • 73949130821 scopus 로고    scopus 로고
    • Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia
    • Van Doorslaer, K., Reimers, L.L., Studentsov, Y.Y., et al. (2009). Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Gynecol. Oncol. 116, 208-212.
    • (2009) Gynecol. Oncol. , vol.116 , pp. 208-212
    • Van Doorslaer, K.1    Reimers, L.L.2    Studentsov, Y.Y.3
  • 50
    • 84866551579 scopus 로고    scopus 로고
    • Vaccine-induced effector-memory CD8+ T-cell responses predict therapeutic efficacy against tumors
    • van Duikeren, S., Fransen, M.F., Redeker, A., et al. (2012). Vaccine-induced effector-memory CD8+ T-cell responses predict therapeutic efficacy against tumors. J. Immunol. 189, 3397-3403.
    • (2012) J. Immunol. , vol.189 , pp. 3397-3403
    • Van Duikeren, S.1    Fransen, M.F.2    Redeker, A.3
  • 51
    • 33746547247 scopus 로고    scopus 로고
    • The biology of interleukin-2 and inter-leukin-15: Implications for cancer therapy and vaccine design
    • Waldmann, T.A. (2006). The biology of interleukin-2 and inter-leukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 595-601
    • Waldmann, T.A.1
  • 52
    • 0032167401 scopus 로고    scopus 로고
    • A plasmid encoding murine granulocyte-macrophage colonystimulating factor increases protection conferred by a malaria DNA vaccine
    • Weiss, W.R., Ishii, K.J., Hedstrom, R.C., et al. (1998). A plasmid encoding murine granulocyte-macrophage colonystimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161, 2325-2332.
    • (1998) J. Immunol. , vol.161 , pp. 2325-2332
    • Weiss, W.R.1    Ishii, K.J.2    Hedstrom, R.C.3
  • 53
    • 40549110815 scopus 로고    scopus 로고
    • Induction of tumorspecific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
    • Welters, M.J., Kenter, G.G., Piersma, S.J., et al. (2008). Induction of tumorspecific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin. Cancer Res. 14, 178-187.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 178-187
    • Welters, M.J.1    Kenter, G.G.2    Piersma, S.J.3
  • 54
    • 33845888804 scopus 로고    scopus 로고
    • Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene
    • Zhang, X., Divangahi, M., Ngai, P., et al. (2007). Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 25, 1342-1352.
    • (2007) Vaccine , vol.25 , pp. 1342-1352
    • Zhang, X.1    Divangahi, M.2    Ngai, P.3
  • 55
    • 70350359428 scopus 로고    scopus 로고
    • Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T-cell responses and anti-tumor effects
    • Zong, J., Peng, Q., Wang, Q., et al. (2009). Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T-cell responses and anti-tumor effects. Oncol. Rep. 22, 953-961.
    • (2009) Oncol. Rep. , vol.22 , pp. 953-961
    • Zong, J.1    Peng, Q.2    Wang, Q.3
  • 56
    • 0030577120 scopus 로고    scopus 로고
    • Papillomavirus infections-A major cause of human cancers
    • zur Hausen, H. ( 1996). Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288, 55-78.
    • (1996) Biochim. Biophys. Acta , vol.1288 , pp. 55-78
    • Zur Hausen, H.1
  • 57
    • 0036559896 scopus 로고    scopus 로고
    • Papillomaviruses and cancer: From basic studies to clinical application
    • zur Hausen, H. ( 2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342-350.
    • (2002) Nat. Rev. Cancer , vol.2 , pp. 342-350
    • Zur Hausen, H.1
  • 58
    • 0036644556 scopus 로고    scopus 로고
    • Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
    • Zwaveling, S., Ferreira Mota, S.C., Nouta, J., et al. (2002). Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol. 169, 350-358.
    • (2002) J. Immunol. , vol.169 , pp. 350-358
    • Zwaveling, S.1    Ferreira Mota, S.C.2    Nouta, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.